Biblio
Export 1476 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is K [Clear All Filters]
“Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1103-1114, 2022.
, “Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.”, J Alzheimers Dis, vol. 86, no. 2, pp. 841-859, 2022.
, “Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.”, J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
, “Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.”, J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
, “Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort.”, J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
, “Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1537-1547, 2022.
, “Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1537-1547, 2022.
, “Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study.”, J Alzheimers Dis, vol. 87, no. 2, pp. 701-710, 2022.
, “Association of Aspirin Use with Reduced Risk of Developing Alzheimer's Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study.”, J Alzheimers Dis, vol. 91, no. 2, pp. 697-704, 2022.
, “Association of Aspirin Use with Reduced Risk of Developing Alzheimer's Disease in Elderly Ischemic Stroke Patients: A Retrospective Cohort Study.”, J Alzheimers Dis, vol. 91, no. 2, pp. 697-704, 2022.
, “Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden.”, J Alzheimers Dis, vol. 89, no. 1, pp. 223-232, 2022.
, “Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1267-1282, 2022.
, “Association of COVID-19 with New-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.
, “Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1603-1609, 2022.
, “Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1603-1609, 2022.
, “Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 89, no. 3, pp. 825-834, 2022.
, “Associations of Pulmonary Function with MRI Brain Volumes: A Coordinated Multi-Study Analysis.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1073-1083, 2022.
, “Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1075-1089, 2022.
, “B Vitamin Supplementation Slows Cognitive Decline in Mild Cognitive Impairment Patients with Frontal Lobe Atrophy.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1453-1461, 2022.
, “Better Subjective Sleep Quality Partly Explains the Association Between Self-Reported Physical Activity and Better Cognitive Function.”, J Alzheimers Dis, vol. 87, no. 2, pp. 919-931, 2022.
, “Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.”, J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
, “Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.”, J Alzheimers Dis, vol. 86, no. 1, pp. 83-109, 2022.
, “Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.”, J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
, “Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.”, J Alzheimers Dis, vol. 90, no. 1, pp. 405-417, 2022.
, “Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.”, J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
,